Infliximab in the treatment of rheumatoid arthritis
A PerdrigerService de Rhumatologie, CHU de Rennes, Hôpital sud, FranceAbstract: Infliximab was the first monoclonal antibody to human necrosis factor alpha (TNFα) developed for treating rheumatoid arthritis (RA). This chimeric antibody binds with high affinity to both sol...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2009-05-01
|
| Series: | Biologics : Targets & Therapy |
| Online Access: | http://www.dovepress.com/infliximab-in-the-treatment-of-rheumatoid-arthritis-a3099 |